V1512 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-004112-51-IT (EUCTR)	14/11/2006	04/12/2006	A randomised, double-blind, double-dummy, two-period, cross-over study to determine the pharmacokine ...	A randomised, double-blind, double-dummy, two-period, cross-over study to determine the pharmacokine ...	Parkinson s disease MedDRA version: 8.1;Level: LLT;Classification code 10061536;Term: Parkinson's di ...	Trade Name: SIRIO*30CPR EFF 25MG+100MG INN or Proposed INN: Melevodopa and decarboxylase inhibitor Tra ...	VERNALIS DEVELOPMENT LIMITED	NULL	Not Recruiting			Female: yes Male: yes			Italy
2	NCT00491998 (ClinicalTrials.gov)	November 2006	26/6/2007	PK, PD and Safety of Multiple Doses of V1512Tablets in PD Patients Compared to Standard Levodopa/Car ...	Randomised, Double-blind, Double-dummy, Two-period, Cross-over Study to Determine the PK, PD and Saf ...	Parkinson's Disease	Drug: V1512;Drug: V1512 and Entacapone	Vernalis (R&D) Ltd	Cita NeuroPharmaceuticals;INC Research	Completed	30 Years	N/A	Both	27	Phase 1/Phase 2	Italy

First Previous1Next Last